血清胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3在川崎病中的作用

彭静, 邓淑珍, 付佳, 等. 血清胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3在川崎病中的作用[J]. 临床心血管病杂志, 2014, 30(1): 65-67. doi: 10.13201/j.issn.1001-1439.2014.01.020
引用本文: 彭静, 邓淑珍, 付佳, 等. 血清胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3在川崎病中的作用[J]. 临床心血管病杂志, 2014, 30(1): 65-67. doi: 10.13201/j.issn.1001-1439.2014.01.020
PENG Jing, DENG Shuzheng, FU Jia, et al. Effect of serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3 on coronary artery lesion in Kawasaki disease[J]. J Clin Cardiol, 2014, 30(1): 65-67. doi: 10.13201/j.issn.1001-1439.2014.01.020
Citation: PENG Jing, DENG Shuzheng, FU Jia, et al. Effect of serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3 on coronary artery lesion in Kawasaki disease[J]. J Clin Cardiol, 2014, 30(1): 65-67. doi: 10.13201/j.issn.1001-1439.2014.01.020

血清胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3在川崎病中的作用

详细信息
    通讯作者: 彭静, E-mail:18627076819@163.com
  • 中图分类号: R541.4

Effect of serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3 on coronary artery lesion in Kawasaki disease

More Information
  • 目的:探讨血清胰岛素样生长因子-1 (IGF-1) 和胰岛素样生长因子结合蛋白-3 (IGFBP-3) 在川崎病发生及冠状动脉损伤 (CAL) 中的作用。方法:采用化学发光法检测52例川崎病患儿 (川崎病组) 血清IGF-1及IGFBP-3水平, 设32例同期住院的感染性疾病患儿为发热对照组, 并将川崎病组分为CAL亚组15例及non-CAL亚组37例, 对各组患儿IGF-1及IGFBP-3水平进行分析比较。结果:52例川崎病组血清IGF-1水平增高, 与发热对照组比较差异有统计学意义 (P<0.05), 血清IGFBP-3水平两组间比较无统计学差异 (P>0.05)。CAL亚组血清IGF-1水平较non-CAL亚组明显增高, 差异具有统计学意义 (P<0.01), 血清IGFBP-3水平两亚组间比较差异无统计学意义 (P>0.05)。结论:IGF-1在川崎病急性期并发CAL时明显增高, 对早期预测冠状动脉病变有一定意义。
  • 加载中
  • [1]

    NAKAMURA Y, YASHIRO M, UEHARA R, et al.Epidemiollogy features of Kawasaki disease in Japan:results of the 2007-2008nationwide survey[J], J Epidemiol, 2010, 20:302-307.

    [2]

    TAKAHASHI K, OHARASEKI T, NAOE S.Pathological study of postcor onary arteritis in adolescencents and young adults:With reference to the relationship bet ween sequelae of Kawasaki disease and atheroscler osis[J].Pediatr Cardiol, 2001, 22:138-142.

    [3]

    蔡招华, 刘亚黎.川崎病患者易早发动脉粥样硬化[J].实用儿科临床杂志, 2011, 26 (9):709-712.

    [4]

    周玉娟, 刘福林, 张永健.胰岛素样生长因子-1对血管平滑肌细胞的作用机制[J].临床荟萃, 2006, 21 (7):525-526.

    [5]

    FREEMAN A F, SHULMAN S T.Kawasaki disease:summary of the American Heart Association guidelines[J].Am Fam Physician, 2006, 74:1141-1148.

    [6]

    PARK Y W, HAN J W, HONG Y M, et al.Epidemiological features of Kawasaki disease in Korea[J].Pediatr Int, 2010, 53:36-40.

    [7]

    YASHIRO M, UCHARA R, OKI I, et al.Yearly changes in gamma globulin treatment for Kawasaki disease patients[J].Nippon Shonika Gakkai Zasshi, 2004, 108:1461-1462.

    [8]

    SATOU G M, GIAMELLI J, GEWITZ M H.Kawasaki disease:diagnosis, management, and longterm implications[J].Cardiol Rev, 2007, 15:163-169.

    [9]

    FUKAZAWA R, I KEGAM E, WATANABE M, et al.Coronary artery aneurys minduced by Kawasaki disease in children show features typ ical senescence[J].Circ J, 2007, 71:709-715.

    [10]

    郭军, 李自成.IGF-1预处理对骨髓间充质干细胞心肌再生及抗炎效果的影响[J].临床心血管病杂志, 2011, 27 (12):1326-1329.

    [11]

    IEMURA M, ISHII M, SUGIMURA T, et al.Long term consequences of regressed coronary aneurysms after Kawasaki disease:Vascular wall morphology and function[J].Heart, 2000, 83:307-311.

    [12]

    秦玉明, 周爱卿, 贲晓明, 沈捷.川崎病患儿血清胰岛素样生长因子1动态变化的研究[J].中华儿科杂志, 2000, 38 (5):317-318.

  • 加载中
计量
  • 文章访问数:  32
  • PDF下载数:  14
  • 施引文献:  0
出版历程
收稿日期:  2012-12-17

目录